FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3122113291> ?p ?o ?g. }

• W3122113291 endingPage "9" @default.
• W3122113291 startingPage "1" @default.
• W3122113291 abstract "Purpose. Previous studies have shown that melanoma cells produce excessive levels of cytokines, which have various biological roles during melanoma development. The aim of this study was to expand the profile of serum cytokines, chemokines, growth factors, and angiogenic factors that are associated with melanoma, to find more cytokines with abnormal concentrations in melanoma patients, to identify whether the level of cytokines correlated with prognostic variants, such as Breslow thickness and BRAF mutation, and, finally, to find out the cytokines that play important roles during melanoma development. Materials and Methods. Multiplex immunobead assay technology and 45-plex immunoassays ProcartaPlex™ kits were used to simultaneously compare the levels of cytokines, growth factors, angiogenic factors, and chemokines between the serum of healthy patients (n = 30) and those with melanoma (n = 72). Data were analyzed according to the clinical characteristics of the designated patient subgroups. Results. Compared to the control group, melanoma patients had higher levels of VEGF-A, PDGF-BB, IL-1RA, PIGF-1, IFN-γ, TNF-α, MIP-1α, and SCF, but lower levels of BDNF, SDF-1α, MCP-1, Eotaxin, EGF, and IL-7. Furthermore, the levels of TNF-α ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M1> <mi>P</mi> <mo>=</mo> <mn>0.320</mn> </math> , r = 0.019), IFN-γ ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M2> <mi>P</mi> <mo>=</mo> <mn>0.311</mn> </math> , r = 0.023), VEGF-A ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M3> <mi>P</mi> <mo>=</mo> <mn>0.014</mn> </math> , r = 0.337), and BDNF (0.004, r = −0.391) showed a significant correlation with Breslow thickness. IL-7 was of lower levels in patients harboring BRAF mutants. Melanoma patients with high levels of MIP-1α and MCP-1 showed the poorest overall survival. Conclusions. We found that the levels of VEGF-A and PDGF-BB in the serum of both primary and metastatic melanoma patients are elevated. TNF-α, IFN-γ, and VEGF-A presented a positive correlation with Breslow thickness, whereas BDNF showed a negative association. MIP-1α and MCP-1 correlated negatively with survival. In addition, lower levels of IL-7 were found in patients harboring BRAF mutants. These findings indicate that these cytokines may play critical roles in the progression of melanoma." @default.
• W3122113291 created "2021-02-01" @default.
• W3122113291 creator A5001021104 @default.
• W3122113291 creator A5017177779 @default.
• W3122113291 creator A5027785940 @default.
• W3122113291 creator A5035208784 @default.
• W3122113291 creator A5063939166 @default.
• W3122113291 creator A5067902635 @default.
• W3122113291 creator A5082237234 @default.
• W3122113291 creator A5085510751 @default.
• W3122113291 date "2021-01-28" @default.
• W3122113291 modified "2023-10-06" @default.
• W3122113291 title "Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis" @default.
• W3122113291 cites W129007473 @default.
• W3122113291 cites W190076815 @default.
• W3122113291 cites W1924003041 @default.
• W3122113291 cites W1968656287 @default.
• W3122113291 cites W1969787193 @default.
• W3122113291 cites W1988860131 @default.
• W3122113291 cites W2018556348 @default.
• W3122113291 cites W2022292514 @default.
• W3122113291 cites W2029875059 @default.
• W3122113291 cites W2030939161 @default.
• W3122113291 cites W2031563062 @default.
• W3122113291 cites W2044315378 @default.
• W3122113291 cites W2046208657 @default.
• W3122113291 cites W2067755082 @default.
• W3122113291 cites W2070271249 @default.
• W3122113291 cites W2072487610 @default.
• W3122113291 cites W2082224552 @default.
• W3122113291 cites W2088012287 @default.
• W3122113291 cites W2116871245 @default.
• W3122113291 cites W2119231821 @default.
• W3122113291 cites W2123991085 @default.
• W3122113291 cites W2126327738 @default.
• W3122113291 cites W2133495780 @default.
• W3122113291 cites W2161579181 @default.
• W3122113291 cites W2166573361 @default.
• W3122113291 cites W2313911142 @default.
• W3122113291 cites W2315288747 @default.
• W3122113291 cites W2414597279 @default.
• W3122113291 cites W2522351024 @default.
• W3122113291 cites W2770795622 @default.
• W3122113291 cites W2947713025 @default.
• W3122113291 cites W2967113395 @default.
• W3122113291 cites W2968629273 @default.
• W3122113291 cites W4211223138 @default.
• W3122113291 doi "https://doi.org/10.1155/2021/6610769" @default.
• W3122113291 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7861916" @default.
• W3122113291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33574842" @default.
• W3122113291 hasPublicationYear "2021" @default.
• W3122113291 type Work @default.
• W3122113291 sameAs 3122113291 @default.
• W3122113291 citedByCount "3" @default.
• W3122113291 countsByYear W31221132912022 @default.
• W3122113291 crossrefType "journal-article" @default.
• W3122113291 hasAuthorship W3122113291A5001021104 @default.
• W3122113291 hasAuthorship W3122113291A5017177779 @default.
• W3122113291 hasAuthorship W3122113291A5027785940 @default.
• W3122113291 hasAuthorship W3122113291A5035208784 @default.
• W3122113291 hasAuthorship W3122113291A5063939166 @default.
• W3122113291 hasAuthorship W3122113291A5067902635 @default.
• W3122113291 hasAuthorship W3122113291A5082237234 @default.
• W3122113291 hasAuthorship W3122113291A5085510751 @default.
• W3122113291 hasBestOaLocation W31221132911 @default.
• W3122113291 hasConcept C13373296 @default.
• W3122113291 hasConcept C143998085 @default.
• W3122113291 hasConcept C164027704 @default.
• W3122113291 hasConcept C17991360 @default.
• W3122113291 hasConcept C203014093 @default.
• W3122113291 hasConcept C2776914184 @default.
• W3122113291 hasConcept C2777658100 @default.
• W3122113291 hasConcept C2777716647 @default.
• W3122113291 hasConcept C2778690821 @default.
• W3122113291 hasConcept C2781188995 @default.
• W3122113291 hasConcept C502942594 @default.
• W3122113291 hasConcept C60644358 @default.
• W3122113291 hasConcept C71924100 @default.
• W3122113291 hasConcept C86803240 @default.
• W3122113291 hasConcept C8891405 @default.
• W3122113291 hasConceptScore W3122113291C13373296 @default.
• W3122113291 hasConceptScore W3122113291C143998085 @default.
• W3122113291 hasConceptScore W3122113291C164027704 @default.
• W3122113291 hasConceptScore W3122113291C17991360 @default.
• W3122113291 hasConceptScore W3122113291C203014093 @default.
• W3122113291 hasConceptScore W3122113291C2776914184 @default.
• W3122113291 hasConceptScore W3122113291C2777658100 @default.
• W3122113291 hasConceptScore W3122113291C2777716647 @default.
• W3122113291 hasConceptScore W3122113291C2778690821 @default.
• W3122113291 hasConceptScore W3122113291C2781188995 @default.
• W3122113291 hasConceptScore W3122113291C502942594 @default.
• W3122113291 hasConceptScore W3122113291C60644358 @default.
• W3122113291 hasConceptScore W3122113291C71924100 @default.
• W3122113291 hasConceptScore W3122113291C86803240 @default.
• W3122113291 hasConceptScore W3122113291C8891405 @default.
• W3122113291 hasLocation W31221132911 @default.
• W3122113291 hasLocation W31221132912 @default.
• W3122113291 hasLocation W31221132913 @default.

• next